CFTR and exocrine pancreatic insufficiency: It is conceivable that early use of ETI in subjects homozygous for the Phe508del CFTR, who are at high risk of severe manifestations, could prevent the onset of pancreatic insufficiency and potentially bronchiectasis, diabetes and other complications [31].